Review

İntravezikal tedavilere yardımcı yöntemler
  • Hüseyin Cihan Demirel
Bull Urooncol 2011; 10: 13-17
Should all patients with non-muscle invaziv bladder tumor receive postoperative early single dose intravesical chemotherapy?
  • Sümer Baltacı
  • Ömer Gülpınar
Bull Urooncol 2012; 11: 30-33
Supportive treatment for patient receiving gemsitabine-cisplatine and suggestions for nursing
  • Yeter Kırdal
Bull Urooncol 2013; 12: 46-49
Can Bladder be Preserved with TURB + Chemotherapy instead of Radical Surgery (Can we Preserve the Bladder from Cancer)
  • Cavit Can
Bull Urooncol 2012; 11: 55-57
Risk Adaptive Neoadjuvant Chemotherapy in Muscle Invasive Bladder Cancer
  • Elif Atağ
  • Aziz Karaoğlu
  • Ömer Küçük
Bull Urooncol 2017; 16: 57-62 DOI: 10.4274/uob.763
Neoadjuvant and adjuvant chemotherapy for muscle invasive bladder cancer
  • Aziz Karaoğlu
  • Utku Oflazoğlu
  • Necla Demir
Bull Urooncol 2013; 12: 58-63
How should be follow-up strategy in stage 1 testicular tumor, are there any novelties?
  • Yakup Kordan
  • Mehmet Çağatay Çiçek
Bull Urooncol 2011; 10: 63-67
Neoadjuvant and adjuvant treatment modalities for prostate cancer
  • Erkan Erkan
  • Gökhan Toktaş
Bull Urooncol 2011; 10: 63-69
A New Era in Metastatic Prostate Cancer: “The Combination of Chemotherapy and Hormonal Treatment as Initial Treatment”
  • İlker Tinay
  • Levent Türkeri
Bull Urooncol 2016; 15: 65-68 DOI: 10.4274/uob.434
Management of post-chemotherapy residual masses in testicular tumor and surgical tecnique
  • Ferhat Ateş
  • Ömer Yılmaz
  • Kadir Vehbi Baykal
Bull Urooncol 2011; 10: 68-74
The Approach to High Risk Bladder Cancers in The Absence of Bacillus Calmette Guérin: What should Be the Treatment and Follow Up?
  • Polat Türker
  • Levent Türkeri
Bull Urooncol 2014; 13: 103-108 DOI: 10.4274/UOB.09
‘Nanotechnology Applications’ in the Treatment of Prostate Cancer
  • Ali Furkan Batur
  • Kerem Gencer Kutman
  • Mustafa Suat Bolat
Bull Urooncol 2015; 14: 150-155 DOI: 10.4274/uob.375
Postchemotherapy Retroperitoneal Lymph Node Dissection
  • Burak Çıtamak
  • Bülent Akdoğan
  • Mesut Altan
  • Haluk Özen
Bull Urooncol 2014; 13: 169-175 DOI: 10.4274/uob.138
Nursing interventions in patients receiving Taxan Chemotherapy
  • Yeter Kırdal
Bull Urooncol 2012; 11: 173-177
Current situation of the clinical stage I nonseminomatous germ cell testis tumour
  • Alim Koşar
  • Osman Ergün
Bull Urooncol 2012; 11: 181-184
Chemotherapy related adverse events in patients with testicular cancer
  • Özgür Tanrıverdi
  • Bülent Karabulut
Bull Urooncol 2012; 11: 196-200

Medical Oncology

Neoadjuvant chemotherapy in muscle invasive bladder cancer
  • Evren Süer
  • Kadir Türkölmez
Bull Urooncol 2012; 11: 74-78
Systemic chemotherapy in metastatic bladder cancer
  • Burcu Çakar
  • Erdem Göker
Bull Urooncol 2012; 11: 79-83

Quality Of Life

How should we manage infertility in testicular cancer patients?
  • Hakan Özveri
  • Enis Rauf Coşkuner
Bull Urooncol 2011; 10: 95-101

Case Report

A Case of Undifferentiated Trophoblastic Bladder Tumor Which Responded to Germ Cell Tumor Treatment Regimen
  • Serdar Çelik
  • Şakir Ongün
  • Güven Aslan
  • Ozan Bozkurt
  • Burçin Tuna
  • Kutsal Yörükoğlu
  • Adil Esen
Bull Urooncol 2014; 13: 258-260 DOI: 10.4274/uob.152

About Journal

Forms

Useful Links

Applications